Back to search
FDAFDA · Food and drugs·Recall number Z-1877-2013

Carestream DRX Evolution System, X-Ray System --- The DRX-Evolution system is a permanently installed diagnostic x-ray system for generation of x-rays for examination of various anatomical regions.

Published August 21, 2013 · Recall initiated: June 3, 2013

Summary

FDA records medical device Class II recall Z-1877-2013, published August 21, 2013 and initiated June 3, 2013. Recalling firm: Carestream Health Inc.; Status: Terminated; Reported quantity: US: 49 units; Foreign: 183 units (revised); Lot: Carestream DRX Evolution Systems using V5.5.410.33 MR2 Software. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to potential for an x-ray exposure technique change.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Carestream Health Inc.
Distributor
Worldwide Distribution - USA (nationwide) including the countries of Austria, Australia, Belgium, Canada, China, Finland, France, Germany, Italy, Korea, Kuwait, Saudi Arabia, Spain, Sweden, Switzerland, Taiwan, United Kingdom.
Lot
Carestream DRX Evolution Systems using V5.5.410.33 MR2 Software
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Carestream DRX Evolution System, X-Ray System --- The DRX-Evolution system is a permanently installed diagnostic x-ray system for generation of x-rays for examination of various anatomical regions. recalled?

Yes. FDA published recall Z-1877-2013 on August 21, 2013. Reported hazard: Due to potential for an x-ray exposure technique change.

What should I do if I have this product?

Voluntary: Firm initiated · Letter